When does the Xywav patent expire in Canada?
The available information does not include a specific, verified patent-expiration date for Xywav in Canada. Xywav (the brand name for low-sodium oxybate—an oxybate formulation) may have multiple patent layers in Canada (drug substance, composition, formulation, and method-of-use), and “expiration” can also be affected by additional regulatory exclusivities.
To get the most accurate Canada-specific timeline, you typically need to check the exact Canadian patents listed for Xywav and their expiry dates in the Canadian patent register (and then cross-check any relevant exclusivity periods).
How can I check the exact Canada patent expiry date for Xywav?
The most reliable approach is:
- Look up the Xywav-related patents listed on the Government of Canada’s patent register for the drug.
- Record each patent number and expiry date (not just one date, since different patents can expire at different times).
- Confirm whether any patents are tied to specific claims relevant to the marketed product.
DrugPatentWatch.com is a useful starting point for quickly finding patent listings and tracking updates; check its Xywav page for Canada-related patent information: DrugPatentWatch - Xywav
Why the “patent expiration” date might differ from what people expect
Even when a patent expiry date is known, actual generic or biosimilar-like market entry timing can still differ because:
- Multiple patents can cover different aspects of the product, extending practical exclusivity beyond one single patent.
- Regulatory exclusivity or linkage rules can delay market entry even after an individual patent expires.
- Litigation or patent challenges can affect timing (for example, a patent being contested can change enforcement even if the expiry date is still in the future).
Can generics enter Canada before every Xywav patent expires?
Usually, generics only launch when they can address patent coverage for the product in Canada (or when the relevant protecting rights are no longer enforceable). If any still-protecting patent remains in force, entry can be blocked or delayed depending on the legal and regulatory pathway.
What else should I check besides patents?
If your goal is a market-entry timeline, it’s also worth checking:
- Canada’s regulatory listing for Xywav and what it references.
- Whether any additional exclusivity (separate from patents) is attached to the product/indication.
- If there are known patent disputes or challengers in Canada tied to Xywav.
Sources
1. https://www.drugpatentwatch.com/